Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
40,595,617
-
Share change
-
+1,646,654
-
Total reported value
-
$388,092,257
-
Price per share
-
$9.56
-
Number of holders
-
70
-
Value change
-
+$15,869,300
-
Number of buys
-
42
-
Number of sells
-
22
Institutional Holders of DICERNA PHARMACEUTICALS INC - COM (DRNA) as of Q1 2018
As of 31 Mar 2018,
DICERNA PHARMACEUTICALS INC - COM (DRNA) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,595,617 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, EcoR1 Capital, LLC, RA CAPITAL MANAGEMENT, LLC, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, VANGUARD GROUP INC, BRIDGER MANAGEMENT, LLC, and Camber Capital Management LP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.